IL308917A - A method for preparing a radiolabeled [18F] compound with low water content during the labeling step - Google Patents

A method for preparing a radiolabeled [18F] compound with low water content during the labeling step

Info

Publication number
IL308917A
IL308917A IL308917A IL30891723A IL308917A IL 308917 A IL308917 A IL 308917A IL 308917 A IL308917 A IL 308917A IL 30891723 A IL30891723 A IL 30891723A IL 308917 A IL308917 A IL 308917A
Authority
IL
Israel
Prior art keywords
preparing
water content
low water
content during
radiolabelled compound
Prior art date
Application number
IL308917A
Other languages
English (en)
Hebrew (he)
Inventor
Torgrim Engell
Graeme Mcrobbie
Alan Clarke
Julian Grigg
Imtiaz Ahmed Khan
Kristine Wikene
Jonathan Shales
Alexander Jackson
Original Assignee
Ge Healthcare Ltd
Torgrim Engell
Graeme Mcrobbie
Alan Clarke
Julian Grigg
Imtiaz Ahmed Khan
Kristine Wikene
Jonathan Shales
Alexander Jackson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd, Torgrim Engell, Graeme Mcrobbie, Alan Clarke, Julian Grigg, Imtiaz Ahmed Khan, Kristine Wikene, Jonathan Shales, Alexander Jackson filed Critical Ge Healthcare Ltd
Publication of IL308917A publication Critical patent/IL308917A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0493—Steroids, e.g. cholesterol, testosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/005—Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/007—Steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
IL308917A 2021-06-16 2022-06-16 A method for preparing a radiolabeled [18F] compound with low water content during the labeling step IL308917A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2108605.3A GB202108605D0 (en) 2021-06-16 2021-06-16 Effect of water content
PCT/EP2022/066483 WO2022263594A1 (en) 2021-06-16 2022-06-16 Method for preparing an [18f] radiolabelled compound with low water content during labelling step

Publications (1)

Publication Number Publication Date
IL308917A true IL308917A (en) 2024-01-01

Family

ID=76954450

Family Applications (1)

Application Number Title Priority Date Filing Date
IL308917A IL308917A (en) 2021-06-16 2022-06-16 A method for preparing a radiolabeled [18F] compound with low water content during the labeling step

Country Status (12)

Country Link
US (2) US20240366808A1 (cg-RX-API-DMAC7.html)
EP (1) EP4355715A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024522770A (cg-RX-API-DMAC7.html)
KR (1) KR20240021888A (cg-RX-API-DMAC7.html)
CN (1) CN117500773A (cg-RX-API-DMAC7.html)
AU (1) AU2022294052A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023026514A2 (cg-RX-API-DMAC7.html)
CA (1) CA3223802A1 (cg-RX-API-DMAC7.html)
GB (1) GB202108605D0 (cg-RX-API-DMAC7.html)
IL (1) IL308917A (cg-RX-API-DMAC7.html)
MX (1) MX2023015076A (cg-RX-API-DMAC7.html)
WO (1) WO2022263594A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201915206D0 (en) 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0520527D0 (en) 2005-10-10 2005-11-16 Ge Healthcare Ltd Automated method
EP2053033A1 (en) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
AU2011213568B2 (en) 2010-02-08 2016-05-12 Lantheus Medical Imaging, Inc. Methods and apparatus for synthesizing imaging agents, and intermediates thereof
EP2657213A1 (en) * 2012-04-24 2013-10-30 Institut National de la Santé et de la Recherche Medicale Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors
DK2880005T3 (en) * 2012-07-30 2016-07-18 Univ Denmark Tech Dtu RADIO FLUOR RING PROCEDURE
WO2016086036A2 (en) * 2014-11-25 2016-06-02 Bristol-Myers Squibb Company Methods and compositions for 18f-radiolabeling of biologics
US10716869B2 (en) * 2016-02-29 2020-07-21 Oncodesign Sa Radiolabeled macrocyclic EGFR inhibitor
ES2907130T3 (es) * 2017-09-26 2022-04-22 Inst Nat Sante Rech Med Darapladib radiomarcado, análogos del mismo y su uso como compuestos para la obtención de imágenes
GB201805253D0 (en) * 2018-03-29 2018-05-16 Ge Healthcare Ltd Ip Solid phase extraction

Also Published As

Publication number Publication date
AU2022294052A1 (en) 2023-12-14
EP4355715A1 (en) 2024-04-24
MX2023015076A (es) 2024-01-18
GB202108605D0 (en) 2021-07-28
KR20240021888A (ko) 2024-02-19
US20250312494A1 (en) 2025-10-09
CA3223802A1 (en) 2022-12-22
BR112023026514A2 (pt) 2024-03-05
WO2022263594A1 (en) 2022-12-22
JP2024522770A (ja) 2024-06-21
US20240366808A1 (en) 2024-11-07
CN117500773A (zh) 2024-02-02

Similar Documents

Publication Publication Date Title
GB2472937B (en) System and method for depth measurement and correction during subsea intervention operations
IL207895A0 (en) A method for detecting igf1r/chr 15 circulating tumor cells using fish
NZ595227A (en) Tricyclic indole derivates as pbr ligands
WO2007064819A3 (en) Devices, systems, and methods for occluding a defect
GB2462602B (en) Method and apparatus for towing offshore wind turbines
GB2464064A (en) Methods and systems of installing cable for measurement of a physical parameter
WO2010077572A3 (en) Method and system of selecting word sequence for text written in language without word boundary markers
EP2035570A4 (en) PROCESS FOR THE PREPARATION OF AMINO ACIDS USING GLYCERIN
IL165596A0 (en) System and method for improving heart perfusion inrest and during exercise
HK40108896A (en) Method for preparing an [18f] radiolabelled compound with low water content during labelling step
ZA202109796B (en) System and method for preparing methanol therewith
HUE069379T2 (hu) A glufozinát-ammónium elõállítási eljárása
GB202304953D0 (en) Preparation method for 2-acetyl-1, 10-phenanthroline
GB202310058D0 (en) Method for preparing ternary precursor
GB2413658B (en) Method for correcting seismic data for receiver movement during data acquisition
EG24393A (en) Method for producing 4-nitroimidazole compound
ZA200608925B (en) Method for safely logging onto a technical system
PL1794152T3 (pl) Sposób wytwarzania enancjomerycznych związków imidazolowych
GB2611841B (en) Method for preparing nanoprobe
GB0400315D0 (en) Method for reconstructing multimedia object data by means of digital-audio-broadcast (DAB) receivers
ZA202302732B (en) Method for preparing 4-aminonaphthalene-2,6-dicarboxylic acid
SI4178969T1 (sl) Postopek za pripravo diosmina
GB202113646D0 (en) Method of preparation of 18F labelled silyl-fluoride compounds
WO2008149112A3 (en) Method and apparatus for mounting a pole into the ground
EP2224780A4 (en) METHOD FOR DETERMINING PAGING TIME INTERVAL DURING WHICH THE BASE STATION EXECUTS UNMOUNTED SERVICE IN A CDMA MOUNTING SYSTEM